The decline in Agilon Health's stock price is directly attributed to the company's Q4 financial results. Typically, financial results are a strong indicator of a company's performance, and negative results or results that do not meet market expectations can lead to a decrease in stock price. Given that the news specifically mentions the company's financial results as the reason for the stock trading lower, it is highly relevant and important for investors. The confidence in this analysis is high due to the clear cause-and-effect relationship between earnings reports and stock price movements.